Income Statement
INSTIL BIO, INC.
TIL
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | 0.00 |
|
Cost of Revenue
|
- | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - |
|
Operating Expenses
|
78.58 | 73.54 | 159.17 | 226.46 | 155.56 |
|
Research & Development
|
24.74 | 11.84 | 39.60 | 141.06 | 107.25 |
|
Selling, General & Administrative
|
27.22 | 44.21 | 47.55 | 62.24 | 48.31 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-78.58 | -73.54 | -159.17 | -226.46 | -155.56 |
|
Non-Operating Income
|
0.21 | 1.41 | -0.58 | -0.56 | -1.20 |
|
Interest Income
|
3.86 | 6.99 | 8.87 | 3.66 | - |
|
Interest Expense
|
5.83 | 8.99 | 5.21 | 1.88 | - |
|
Other Non-Op Income / Expense
|
- | - | - | - | - |
|
Income Before Tax
|
-71.37 | 74.14 | -156.09 | -225.25 | -156.76 |
|
Income Tax Expense
|
- | - | 0.00 | -2.07 | 0.04 |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
-71.37 | -74.14 | -156.09 | -223.18 | -156.79 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-78.05 | -69.93 | -154.41 | -220.47 | -152.81 |
|
Earnings Per Share (Basic)
|
-10.70 | -11.39 | -24.00 | -1.72 | -1.48 |
|
Diluted EPS
|
-10.70 | -11.39 | -24.00 | -1.72 | -1.48 |
|
Weighted Average Shares
|
6.67 | 6.51 | 6.50 | 129.51 | 105.99 |
|
Diluted Weighted Avg Shares
|
6.67 | 6.51 | 6.50 | 129.51 | 105.99 |
|
Comprehensive Income
|
-71.73 | -74.02 | -155.94 | -223.58 | -156.60 |